NLRP3 and neoplasm: In this regard, LPS and ATP were used for canonical NLRP3 inflammasome activation and pyroptosis induction, while MCC950 was used for specific inhibition of NLRP3 and IL-1β release, after which PTX was added to suppress the proliferation of tumor cells and programmed cell death initiation.